Growth Metrics

Innoviva (INVA) FCF Margin Growth (1y) (2012 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin Growth (1y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 5,389.00
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 1,525.00
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -341.00
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 43,511.00
10 Innoviva 1.60 Bn 992.84 Mn 75.83 Mn -1,935.00

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -1,935.00
Sep 30, 2025 -1,325.00
Jun 30, 2025 19.00
Mar 31, 2025 -378,024.00
Sep 30, 2024 -1,558.00
Jun 30, 2024 -385,236.00
Mar 31, 2024 61,261.00
Sep 30, 2023 -1.47 Mn
Jun 30, 2023 -30,048.00
Mar 31, 2023 -471,384.00
Sep 30, 2022 1.46 Mn
Jun 30, 2022 -304,775.00
Mar 31, 2022 4,636.00
Sep 30, 2021 18,717.00
Jun 30, 2021 714,328.00
Mar 31, 2021 779,658.00
Dec 31, 2020 1.68 Mn
Sep 30, 2020 -323.00
Jun 30, 2020 1,295.00
Mar 31, 2020 -4,553.00
Dec 31, 2019 1,069.00
Sep 30, 2019 -1,017.00
Jun 30, 2019 1,103.00
Mar 31, 2019 4,362.00
Dec 31, 2018 852.00
Sep 30, 2018 806.00
Jun 30, 2018 3,844.00
Mar 31, 2018 2,673.00
Dec 31, 2017 2,056.00
Sep 30, 2017 2,952.00
Jun 30, 2017 31.00
Mar 31, 2017 3,857.00
Dec 31, 2016 1,800.00
Sep 30, 2016 4,030.00
Jun 30, 2016 1,794.00
Mar 31, 2016 5,351.00
Dec 31, 2015 9,544.00
Sep 30, 2015 212,879.00
Jun 30, 2015 573,143.00
Mar 31, 2015 667,609.00
Dec 31, 2014 272,107.00
Sep 30, 2014 790,212.00
Jun 30, 2014 -439,658.00
Mar 31, 2014 -425,098.00
Dec 31, 2013 -280,593.00
Sep 30, 2013 -804,405.00
Jun 30, 2013 538,288.00
Mar 31, 2013 -241,491.00
Dec 31, 2012 50,947.00
Sep 30, 2012 -166,729.00
Jun 30, 2012 -639,773.00
Mar 31, 2012 39,704.00